| IRFCX | VGRNX | IRFCX / VGRNX | |
| Total Expense Ratio | 2.00 | 0.11 | 1,818% |
| Annual Report Gross Expense Ratio | 2.13 | 0.11 | 1,936% |
| Fund Existence | 21 years | 15 years | - |
| Gain YTD | 20.108 | 21.905 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 271M | 3.87B | 7% |
| Annual Yield % from dividends | 2.07 | 4.36 | 47% |
| Returns for 1 year | 14.17 | 16.93 | 84% |
| Returns for 3 years | 11.59 | 24.62 | 47% |
| Returns for 5 years | -6.99 | 5.33 | -131% |
| Returns for 10 years | 22.66 | 28.31 | 80% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CBHCX | 8.48 | 0.05 | +0.59% |
| Victory Market Neutral Income C | |||
| MRIBX | 26.08 | -0.12 | -0.46% |
| MFS Research International B | |||
| GREYX | 9.49 | -0.09 | -0.94% |
| GuideStone Funds Global Rl Est Secs Inst | |||
| GLNIX | 24.58 | -0.25 | -1.01% |
| MFS Global New Discovery I | |||
| AVUSX | 20.92 | -0.34 | -1.60% |
| Avantis® U.S. Equity Institutional | |||